Literature DB >> 11999578

A pediatric case of secondary leukemia associated with t(16;21)(q24;q22) exhibiting the chimeric AML1-MTG16 gene.

Kensuke Kondoh1, Yuji Nakata, Toshiya Furuta, Fumie Hosoda, Toshie Gamou, Yoshihiro Kurosawa, Akitoshi Kinoshita, Misao Ohki, Yukiharu Tomita, Taijiro Mori.   

Abstract

A chimeric gene, AML1-MTG16, showing high homology to AML1-MTG8, was recently identified in adult leukemic patients with the abnormal karyotype t(16;21)(q24;q22). We recently saw a child patient of 11 years of age who developed acute myelogenous leukemia with the karyotype t(16;21)(q24;q22), 11 months after autologous peripheral blood stem-cell transplantation (PBSCT) for acute promyelocytic leukemia with karyotype t(15;17)(q22;q11). The reciprocal translocation was localized by fluorescence in situ hybridization (FISH) analysis, reverse transcription polymerase chain reaction (RT-PCR), and Southern blot analysis of bone marrow blood cells and peripheral blood cells. FISH analysis identified a reciprocal translocation between chromosomes 16 and 21. RT-PCR analysis identified expression of the chimeric gene AML1-MTG16. Southern blot analysis revealed a breakpoint occurring at a 1.4 kb Eco RI fragment between exons 3 and 4 of MTG16. The breakpoint is within the same region as that of secondary leukemias, which has been reported previously. This case suggests the possibility that the region of the breakpoint of MTG16 is a characteristic of secondary leukemia.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11999578     DOI: 10.1080/10428190290006242

Source DB:  PubMed          Journal:  Leuk Lymphoma        ISSN: 1026-8022


  2 in total

1.  Childhood acute myeloid leukemia with bone marrow eosinophilia caused by t(16;21)(q24;q22).

Authors:  Nozomu Kawashima; Akira Shimada; Takeshi Taketani; Yasuhide Hayashi; Nao Yoshida; Kimikazu Matsumoto; Yoshiyuki Takahashi; Seiji Kojima; Koji Kato
Journal:  Int J Hematol       Date:  2012-03-09       Impact factor: 2.490

2.  Prognostic impact of t(16;21)(p11;q22) and t(16;21)(q24;q22) in pediatric AML: a retrospective study by the I-BFM Study Group.

Authors:  Sanne Noort; Martin Zimmermann; Dirk Reinhardt; Wendy Cuccuini; Martina Pigazzi; Jenny Smith; Rhonda E Ries; Todd A Alonzo; Betsy Hirsch; Daisuke Tomizawa; Franco Locatelli; Tanja A Gruber; Susana Raimondi; Edwin Sonneveld; Daniel K Cheuk; Michael Dworzak; Jan Stary; Jonas Abrahamsson; Nira Arad-Cohen; Malgorzata Czogala; Barbara De Moerloose; Henrik Hasle; Soheil Meshinchi; Marry van den Heuvel-Eibrink; C Michel Zwaan
Journal:  Blood       Date:  2018-08-27       Impact factor: 22.113

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.